BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36332168)

  • 1. Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells.
    Goldman A; Raschi E; Chapman J; Santomasso BD; Pasquini MC; Perales MA; Shouval R
    Blood; 2023 Feb; 141(6):673-677. PubMed ID: 36332168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy in the era of chimeric antigen receptor T-cell therapy.
    Mackenzie S; Laurence A; O'Reilly M; Peggs KS; Roddie C
    Lancet Haematol; 2021 Dec; 8(12):e870-e873. PubMed ID: 34826407
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy after CAR T therapy.
    Sdrimas K; Diaz-Paez M; Camargo JF; Lekakis LJ
    Int J Hematol; 2020 Jul; 112(1):118-121. PubMed ID: 32125605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BK virus-specific T cells for immunotherapy of progressive multifocal leukoencephalopathy: an open-label, single-cohort pilot study.
    Cortese I; Beck ES; Al-Louzi O; Ohayon J; Andrada F; Osuorah I; Dwyer J; Billioux BJ; Dargah-Zada N; Schindler MK; Binder K; Reoma L; Norato G; Enose-Akahata Y; Smith BR; Monaco MC; Major EO; Jacobson S; Stroncek D; Highfill S; Panch S; Reich DS; Barrett J; Nath A; Muranski P
    Lancet Neurol; 2021 Aug; 20(8):639-652. PubMed ID: 34302788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy.
    Mian A; Andrapalliyal N; Weathers AL; Pohlman B; Hill BT
    Eur J Haematol; 2021 Apr; 106(4):584-588. PubMed ID: 33459429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal Necrotizing Leukoencephalopathy With Preferential Microglia Toxicity in a Patient Treated With Chimeric Antigen Receptor T-Cells and Review of the Literature.
    Marker DF; Kofler JK; Mettenburg JA; Agha ME; Wiley CA
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1115-1121. PubMed ID: 32954433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis.
    Schröder A; Lee DH; Hellwig K; Lukas C; Linker RA; Gold R
    Arch Neurol; 2010 Nov; 67(11):1391-4. PubMed ID: 20625069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare.
    Berger JR; Concha M
    J Neurovirol; 1995 Mar; 1(1):5-18. PubMed ID: 9222338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged Immunosuppression in Relapsed, Refractory Multiple Myeloma Leading to Cerebral Toxoplasmosis and Progressive Multifocal Leukoencephalopathy.
    Yeung J; van Hal S; Ho PJ
    Clin Lymphoma Myeloma Leuk; 2019 Dec; 19(12):e625-e628. PubMed ID: 31676197
    [No Abstract]   [Full Text] [Related]  

  • 10. Progressive multifocal leukoencephalopathy mimicking glioma in a patient with idiopathic CD4 lymphocytopenia.
    Gupta HV; Gokden M; Ramakrishnaiah RH; Archer RL
    Acta Neurol Belg; 2016 Sep; 116(3):391-4. PubMed ID: 26319126
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive multifocal leukoencephalopathy: a case study.
    McCalmont V; Bennett K
    Prog Transplant; 2007 Jun; 17(2):157-60. PubMed ID: 17624139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.
    Sospedra M; Schippling S; Yousef S; Jelcic I; Bofill-Mas S; Planas R; Stellmann JP; Demina V; Cinque P; Garcea R; Croughs T; Girones R; Martin R
    Clin Infect Dis; 2014 Dec; 59(11):1588-92. PubMed ID: 25214510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent progressive multifocal leukoencephalopathy and central nervous system infiltration by multiple myeloma: A case report.
    Ruiz-Heredia Y; Sanchez-Vega B; Barrio S; Linares M; Rapado I; Braggio E; Stewart K; Folgueira MD; Ramos A; Collado L; Ruiz J; Toldos O; Hernandez-Lain A; Martinez-Lopez J
    J Oncol Pharm Pract; 2019 Jun; 25(4):998-1002. PubMed ID: 29690814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive Transfer of JC Virus-Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy.
    Berzero G; Basso S; Stoppini L; Palermo A; Pichiecchio A; Paoletti M; Lucev F; Gerevini S; Rossi A; Vegezzi E; Diamanti L; Bini P; Gastaldi M; Delbue S; Perotti C; Seminari E; Faraci M; Luppi M; Baldanti F; Zecca M; Marchioni E; Comoli P
    Ann Neurol; 2021 Apr; 89(4):769-779. PubMed ID: 33459417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric immune receptors (CIRs) specific to JC virus for immunotherapy in progressive multifocal leukoencephalopathy (PML).
    Yang W; Beaudoin EL; Lu L; Du Pasquier RA; Kuroda MJ; Willemsen RA; Koralnik IJ; Junghans RP
    Int Immunol; 2007 Sep; 19(9):1083-93. PubMed ID: 17660502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus-induced T-cell proliferation and the development of progressive multifocal leucoencephalopathy following bone marrow transplantation.
    Owen RG; Patmore RD; Smith GM; Barnard DL
    Br J Haematol; 1995 Jan; 89(1):196-8. PubMed ID: 7833263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natalizumab-associated progressive multifocal leukoencephalopathy: successful treatment without plasma exchange and its associated risks.
    Maloney E; Molloy A; Al Hussona M; O'Donnell L; Killeen R; McGuigan C
    J Neurol; 2017 Feb; 264(2):401-403. PubMed ID: 28039520
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive multifocal leukoencephalopathy developed 26 years after renal transplantation.
    Nagayama S; Gondo Y; Araya S; Minato N; Fujita-Nakata M; Kaito M; Nakanishi M; Tanaka K; Yamaya H; Yokoyama H; Nakamichi K; Saijo M; Okamoto K; Toyoshima Y; Kakita A; Matsui M
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1482-4. PubMed ID: 23253820
    [No Abstract]   [Full Text] [Related]  

  • 19. Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab.
    Martinot M; Ahle G; Petrosyan I; Martinez C; Gorun DM; Mohseni-Zadeh M; Fafi-Kremer S; Tebacher-Alt M
    Emerg Infect Dis; 2018 Aug; 24(8):1594-1596. PubMed ID: 30016251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy: clinical and MR response to treatment.
    Garrels K; Kucharczyk W; Wortzman G; Shandling M
    AJNR Am J Neuroradiol; 1996 Mar; 17(3):597-600. PubMed ID: 8881262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.